NSIV is pleased to announce that one of its members, CrowdComfort, has been selected as a finalist in Salem State University’s Enterprise Center “2014 Business Plan Competition.” CrowdComfort and two other finalists will have an opportunity to present their business plans before a live panel of judges and compete for first, second, andRead more
Blog
Barry Yomtov, CTO of AdvaStim, will be a presenter at The Neurotech Investing & Partnering Conference 2014 on Wednesday, April 23. Now in its 9th year, The Neurotech Conference is a two-day global forum where investors, executives, entrepreneurs, scientists, and others involved in the development of new treatments and diagnostics for the brain and nervousRead more
AdvaStim’s novel hardware and software platform gives developers capabilities to address current and emerging clinical indications. BEVERLY, Mass., April 23, 2014, AdvaStim, Inc., www.advastim.com, a leading developer of advanced technology platforms for neuromodulation therapies, announced today that the Company has entered the research and development market with a new hardware/software solution for neuromodulation therapy developers.Read more